Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Preliminary data on early redemptions (prepayments)
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
WENDEL: Investor conference calls ahead of the launch of a potential €500 million 8-year bond issue
-
Sydbank A/S share buyback programme: transactions in week 31
-
Man Group PLC : Form 8.3 - Spirent Communications Plc
-
STAKE Soft Unveils Groundbreaking AI-Powered Mirror Link Generator to Fortify Websites Against 2025's Evolving Cyber Threats
-
Cervical Disc Replacement vs. Cervical Fusion: Which One Might Help You Get Your Life Back?
-
Prepayments, Realkredit Danmark A/S
-
Alm. Brand A/S – Weekly report on share buybacks
-
Bad Credit Check Loan Guaranteed Approval Searches Surge: RadCred Launches Instant Loan No Credit Check Loan Comparison for U.S. Borrowers in 2025
-
Exhale Wellness Recognized as the #1 Delta 9 THC Gummies by Onpattison
-
SimCorp names Peter Sanderson as Chief Executive Officer
-
Hyper Bit Orders Next Generation ElphaPex DG2 Miners and Launches New Community Focused Hyper Bit Game
-
Advantest will Showcase Latest Memory Test Solutions at Future of Memory and Storage 2025
-
Repurchase of Truecaller B shares in week 31, 2025
-
2025 CrowdStrike Threat Hunting Report: Adversaries Weaponize and Target AI at Scale
-
HKBU leads the development of multifunctional nanorobots for precise and effective pollutant degradation and bacterial removal
-
Viewpoint with Dennis Quaid and DeKalb Convention & Visitors Bureau Present: Your Passport to a World of Culture
-
Motive Launches in the UK to Power Safer, Smarter, More Sustainable Fleet Operations with AI
-
Legatum on Track for Initial Commitments of Over $US30 Million for New Collaborative Fund to Transform Crisis Relief
-
Guggenheim Securities Expands Global Technology & Services Investment Banking Businesses
-
Guggenheim Securities Expands Global Technology & Services Investment Banking Businesses
-
New Way to Take Iron: IBSA Launches Innovative Orally Dissolving Film Supplement That’s Gentle on the Stomach and Easy to Take
-
LYNO AI Presale Gains Momentum as Over 100,000 Tokens Sold in Early Bird Stage
-
Share buyback programme - week 31
-
TCM Group A/S: Major shareholder announcement
-
Check Out Jackbit Crypto Casino Bonus for US Players: Get 100 Free Spins with No Wagering Requirements
-
AS Ekspress Grupp sells a shareholding in a Latvian company
-
Casino Group: Repayments confirmation to Quatrim secured bondholders
-
Syensqo - Participation notification by BlackRock Inc.
-
Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease
-
Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
-
Updated composition of the management team of Oma Savings Bank
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Antin Infrastructure Partners: Information on the Total Number of Shares and Voting Rights
-
Oma Savings Bank Plc’s Half-Year Financial Report January-June 2025: Core business on a solid foundation – the improvement of operating models is progressing
-
Aktsiaselts Infortar unaudited consolidated interim report for Q2 2025
-
OCI Confirms Q3 2025 USD 700 Million Extraordinary Cash Distribution
-
Kosmos Energy Announces Second Quarter 2025 Results
-
Alcoa Explores Feasibility of Gallium Critical Mineral Production in Western Australia
-
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
-
BTS Group AB (publ) announces earnings update for the second quarter and lowered outlook for 2025
-
EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing
-
Elis: Disclosure of trading in own shares occured from July 28 to August 1, 2025
-
NBPE Announces Transaction in Own Shares
-
Network API Revenue to Exceed $8 Billion by 2030 Globally, as KYC Identified as the Next Major Opportunity
-
Pharming Group to participate in August investor conference
-
AB Science announces the successful completion of a 2.55 million euros private placement
-
Akeso Announces Approval to Initiate Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma
